WhichRecall
Class IIReported 2025-08-20

Carvedilol Tablets, USP, 25 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd, Colvale-Bardez, Goa, 403513, India. Manufactured for Glenmark Pharmaceuticals, Inc., USA, Mahwah, NJ 07430. NDC 68462-165-05

Recalled by Glenmark Pharmaceuticals Inc., USA

Reason for Recall

CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.

Advertisement
Recall Number
D-0579-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-08-07
Reported
2025-08-20
Distribution
Nationwide in the USA
Code Info
Lot#:19243104, Expires: 7/31/2026.
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement